Profiling insulin like factor 3 (INSL3) signaling in human osteoblasts

Alberto Ferlin1, Lisa Perilli, Lisa Gianesello

  • 1Section of Clinical Pathology, Department of Histology, Microbiology and Medical Biotechnologies, University of Padova, Padova, Italy.

Plos One
|January 5, 2012
PubMed
Summary

The INSL3/RXFP2 system influences bone metabolism. INSL3 signaling in osteoblasts activates the MAPK pathway, promoting osteoblast differentiation and mineralization, crucial for bone health.